SynthesisOncology2026

Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia: A Systematic Review.

Amna Gameil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.